We are the original cannabis seed bank, pioneering in cultivation and genetics since 1999.MSNL has evolved from our first line of 20 cannabis strains to a vast catalogue of over 200, grown and harvested by our team of breeders. Our commitment is to offer the highest quality seeds for both medical and recreational growers. With our germination guarantee, free seeds with every …

Mesothelin, also known as MSLN, is a protein that in humans is encoded by the MSLN gene. [5] [6]

The Maine School and Library Network provides internet access, email, web hosting, and other internet related services to almost 1000 schools and libraries across the state of Maine. For more information on MSLN, please go the the About MSLN section.

2024年12月25日 · Complete information for MSLN gene (Protein Coding), Mesothelin, including: function, proteins, disorders, pathways, orthologs, and expression. GeneCards - The Human Gene Compendium New to GeneCards?

2021年4月7日 · Mesothelin (MSLN) represents an attractive molecule for targeted cancer therapies. To identify tumors that might benefit from such therapies, tissue microarrays including 15,050 tumors from 122 different tumor types and 76 healthy organs were analyzed for MSLN expression by immunohistochemistry.

2020年12月1日 · Mesothelin (MSLN) is a lineage restricted cell surface protein expressed in about 30% of human cancers and high MSLN expression is associated with poor survival in several different cancers.

2021年5月3日 · MSLN was highly expressed in patients with KMT2A rearrangements (P < .001), core-binding factor fusions [inv(16)/t(16;16), P < .001; t(8;21), P < .001], and extramedullary disease (P = .001). We also demonstrated the presence of soluble MSLN in diagnostic serum specimens using an MSLN-directed enzyme-linked immunosorbent assay.

2019年8月23日 · Mesothelin (MSLN), a tumor-associated antigen broadly overexpressed on various malignant tumor cells, while its expression is generally limited to normal mesothelial cells, is an attractive candidate for targeted therapy.

Since its discovery in 1992, mesothelin (MSLN) has generated significant interest as a therapeutic target. A number of characteristics make it ideal for this purpose. First, it is not expressed on the parenchyma of any vital organs.

2025年3月4日 · Title: Effects of hsa-mir-145-5p on the Regulation of msln Expression in Colorectal Adenocarcinoma. Mesothelin Expression Is Not Associated with the Presence of Cancer Stem Cell Markers SOX2 and ALDH1 in Ovarian Cancer.